These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
365 related articles for article (PubMed ID: 10662)
1. [Blood platelets and cardiovascular diseases. IV. Platelet-inhibiting drugs and antithrombotic agents]. Jobin F Union Med Can; 1976 Aug; 105(8):1159-73. PubMed ID: 10662 [No Abstract] [Full Text] [Related]
2. Influence of some drugs on platelet aggregation: a study in hypertensive patients. Bologna E Acta Univ Carol Med Monogr; 1972; 52():87-92. PubMed ID: 4669830 [No Abstract] [Full Text] [Related]
3. Effect of acetylsalicylic acid, other nonsteroidal anti-inflammatory agents, and dipyridamole on human blood platelets. Zucker MB; Peterson J J Lab Clin Med; 1970 Jul; 76(1):66-75. PubMed ID: 5425364 [No Abstract] [Full Text] [Related]
5. Aspirin and other platelet-aggregation inhibiting drugs. Gallus AS Med J Aust; 1985 Jan; 142(1):41-7. PubMed ID: 3880861 [TBL] [Abstract][Full Text] [Related]
6. Effects of nonsteroid anti-inflammatory agents and some dicoumarol derivatives on platelet aggregation, fibrinolysis and stabilization of cell membrane in vitro. Roubal Z; Grimová J; Nĕmecek O; Cepelák V Acta Univ Carol Med Monogr; 1972; 53():229-35. PubMed ID: 4133930 [No Abstract] [Full Text] [Related]
7. Effects of platelet-modifying drugs on arterial thromboembolism in baboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition. Hanson SR; Harker LA; Bjornsson TD J Clin Invest; 1985 May; 75(5):1591-9. PubMed ID: 3923041 [TBL] [Abstract][Full Text] [Related]
8. [Effect of drugs on blood platelet characteristics]. Zbinden G Schweiz Med Wochenschr; 1971 Nov; 101(46):1658-62. PubMed ID: 5140632 [No Abstract] [Full Text] [Related]
10. Effect of 4,5-diphenyl-2-bis-(2-hydroxyethyl)aminoxazol (ditazol) on platelet aggregation, adhesiveness and bleeding time. Caprino L; Borrelli F; Falchetti R Arzneimittelforschung; 1973 Sep; 23(9):1277-83. PubMed ID: 4801220 [No Abstract] [Full Text] [Related]
11. Antiplatelet therapy (first of two parts). Weiss HJ N Engl J Med; 1978 Jun; 298(24):1344-7. PubMed ID: 651993 [No Abstract] [Full Text] [Related]
12. The effect of platelet function inhibitors on experimental venous thrombosis formation in rabbits. Arfors KE; Bergqvist D; Tangen O Acta Chir Scand; 1975; 141(1):40-2. PubMed ID: 1092111 [TBL] [Abstract][Full Text] [Related]
13. The role of platelets in glomerulonephritis. George CR; Clark WF; Cameron JS Adv Nephrol Necker Hosp; 1975; 5():19-65. PubMed ID: 242207 [No Abstract] [Full Text] [Related]
14. Proceedings: Comparison of in vivo and in vitro effects of platelet function suppressing drugs. Buchanan M; Hirsh J Thromb Diath Haemorrh; 1975 Nov; 34(2):552. PubMed ID: 1198423 [No Abstract] [Full Text] [Related]
15. An overview of antiplatelet and antithrombotic drugs. Verstraete M; Dejana E; Fuster V; Lapetina E; Moncada S; Mustard JF; Tans G; Vargaftig BB Haemostasis; 1985; 15(2):89-99. PubMed ID: 3159632 [No Abstract] [Full Text] [Related]
16. The role of platelets in thrombotic and vascular disease. Schafer AI; Handin RI Prog Cardiovasc Dis; 1979; 22(1):31-52. PubMed ID: 379914 [No Abstract] [Full Text] [Related]
17. In vitro evaluation of inhibitors of platelet release and aggregation. Rosenberg JC; Sell TL Arch Surg; 1975 Aug; 110(8):980-3. PubMed ID: 168838 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of platelet aggregation by drugs. Glusa E Acta Univ Carol Med Monogr; 1972; 52():83-6. PubMed ID: 4669829 [No Abstract] [Full Text] [Related]